BCBA/TMO (BCBA/TMO)

Buenos Aires Stock Exchange: BCBA/TMO · ARS

ARS 53,100

+925.00 (+1.8%)· Recorded snapshot

Market cap	400.3T
Revenue (ttm)	72.1T
Net income (ttm)	10.8T
EPS (ttm)	ARS 1,430
P/E (trailing)	37.1x
P/E (forward)	26.1x
Dividend	ARS 76.4 (0.14%)
Volume	7,132

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72.1T
Net income (ttm): 10.8T
EPS (ttm): ARS 1,430
P/E (trailing): 37.1x
P/E (forward): 26.1x
Market cap: 400.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E26.1

P25 n/aP50 n/aP75 n/a

Trailing P/E37.1

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/TMO indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	125,000
Employees change	3,000
Employees growth	2.46%
Enterprise value	ARS 454.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-26
First seen	2026-05-10
Fiscal year end	December
Founded	1956
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	ARBCOM4601F7
Last earnings date	2026-10-21
Last refreshed	2026-10-29
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 400.3T
Price	ARS 53,100.00
Price currency	ARS
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	bcba/TMO
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.57x
Average P/E ratio (3Y)	31.2x
Average P/E ratio (5Y)	31.63x
Earnings yield	2.69%
EV/Earnings	42.21x
EV/EBIT	32.76x
EV/EBITDA	23.42x
EV/FCF	39.3x
EV/Sales	6.25x
FCF / EV yield	2.54%
FCF yield	2.89%
Forward P/E	26.14x
Graham number	18888.98859
Graham upside	-64.43%
Lynch fair value	ARS 7,146.48
Lynch upside	-86.54%
P/(FCF - SBC) ratio	36.06x
P/(OCF - SBC) ratio	29.15x
P/B ratio	4.79x
P/E ratio	37.12x
P/FCF ratio	34.59x
P/OCF ratio	28.18x
P/S ratio	5.55x
Price/EBITDA ratio	21.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.2%
EBITDA margin	25.76%
Effective tax rate	9.48%
FCF margin	15.85%
Gross margin	41.18%
Operating margin	19.2%
Pretax margin	16.55%
Profit margin	14.94%
Profit per employee	ARS 86.2M
Profitable quarters	98
Profitable years	24
Revenue per employee	ARS 577.1M
ROA	5.23%
ROA (5Y)	5.62%
ROCE	9.09%
ROE	13.38%
ROE (5Y)	15.21%
ROIC	9.07%
ROIC (5Y)	10.84%
SBC / revenue	0.65%
Tax / revenue	1.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.54%
EPS growth (Q)	8.67%
EPS growth (QoQ)	-0.84%
EPS growth 10Y	14.26%
EPS growth 3Y	7.53%
EPS growth 5Y	-2.52%
EPS growth quarters	7
EPS growth years	2
FCF growth	24.3%
FCF growth (Q)	15.15%
FCF growth (QoQ)	26.15%
FCF growth 3Y	5.08%
FCF growth 5Y	-0.82%
Gross profit growth	7.71%
Gross profit growth (Q)	13.24%
Gross profit growth 3Y	3.89%
Gross profit growth 5Y	-0.46%
Net income growth	7.64%
Net income growth (Q)	6.5%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	5.98%
Net income growth 5Y	-3.76%
Net income growth quarters	3
Net income growth years	2
OCF growth	21.87%
OCF growth (Q)	13.89%
OCF growth (QoQ)	20%
OCF growth 10Y	11.01%
OCF growth 3Y	4.5%
OCF growth 5Y	-1.77%
Operating income growth	11.07%
Operating income growth (Q)	14.32%
Operating income growth 3Y	6.53%
Operating income growth 5Y	-3.21%
Revenue growth	8.27%
Revenue growth (Q)	9.13%
Revenue growth (QoQ)	1.19%
Revenue growth 10Y	10.17%
Revenue growth 3Y	2.93%
Revenue growth 5Y	3.93%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -2.6T
Depreciation and amortization	ARS 4.8T
EBIT	ARS 13.9T
EBITDA	ARS 18.6T
EPS	ARS 1,430.34
Financing cash flow	ARS 3T
Free cash flow	ARS 11.6T
Free cash flow minus SBC	ARS 11.1T
Gross profit	ARS 29.7T
Income taxes	ARS 1.1T
Investing cash flow	ARS -12.2T
Net borrowing	ARS 9.8T
Net cash flow	ARS 5.3T
Net income	ARS 10.8T
Operating cash flow minus SBC	ARS 13.7T
Operating income	ARS 13.9T
Revenue	ARS 72.1T
Stock-based compensation	ARS 472.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 225,506.82
Debt / EBITDA	3.26
Debt / equity	0.75
Debt / FCF	5.45
Goodwill	ARS 83.7T
Interest coverage	5.92
Long-term assets	ARS 134.5T
Long-term liabilities	ARS 68.6T
Net cash (debt)	ARS -53.8T
Net cash / market cap	-13.44%
Net debt / EBITDA	2.89
Net debt / equity	0.64
Net debt / FCF	4.65
Piotroski F-Score	6
Property, plant and equipment	ARS 16.3T
Shareholders' equity	ARS 83.6T
Tangible book value	ARS -26.8T
Tangible book value per share	ARS -72,358.01
Total assets	ARS 174T
Total cash	ARS 9.2T
Total debt	ARS 63T
Total liabilities	ARS 90.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	ARS 39.5T
Current liabilities	ARS 21.8T
Current ratio	1.81
Inventory turnover	4.89
Net working capital	ARS 11.6T
Quick ratio	1.11
Working capital	ARS 17.4T
Working capital turnover	7,653.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.52%
Dividend growth	33.76%
Dividend growth (3Y)	100.27%
Dividend growth (5Y)	96.99%
Dividend growth years	6
Dividend payment date	2026-10-15
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	ARS 76.40
Dividend yield	0.14%
Ex-dividend date	2026-09-15
Last dividend	ARS 20.41
Payout ratio	9.52%
Shareholder yield	1.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 39,168.73
1D price change	1.77%
1M price change	7.6%
1M total return	7.6%
1W price change	3.29%
1W total return	3.29%
1Y price change	47.62%
1Y return CAGR	48.01%
1Y total return	47.97%
20-day SMA	ARS 49,925.50
200-day SMA	ARS 38,711.35
3M price change	31.6%
3M total return	31.69%
3Y price change	215.73%
3Y return CAGR	46.97%
3Y total return	217.56%
50-day SMA	ARS 47,563.40
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 53,350.00
52-week high date	2026-10-28
52-week low	ARS 29,480.00
52-week low date	2026-05-15
5Y price change	856.18%
5Y return CAGR	57.31%
5Y total return	863.13%
6M price change	65.17%
6M total return	65.39%
All-time high	ARS 53,350.00
All-time high date	2026-10-28
All-time low	ARS 1,732.75
All-time low date	2020-05-26
Average true range (ATR)	ARS 1,066.76
Average volume	567.4
Change from 52-week high	-0.47%
Change from 52-week low	80.12%
Change from all-time high	0%
Change from all-time low	2,978.92%
Change from open	0.24%
Day's gap	1.53%
Dollar volume	ARS 378.7M
High price	ARS 53,350.00
Low price	ARS 51,000.00
Monthly RSI	75.7
Open price	ARS 52,975.00
Position in 52-week range	89.36%
Previous close	ARS 52,175.00
Price vs 150-day SMA	36.21%
Price vs 20-day SMA	6.86%
Price vs 200-day SMA	37.81%
Price vs 50-day SMA	12.17%
Relative volume	12.57
RSI	69.29
Sharpe ratio	1.18
Sharpe ratio (3Y)	0.95
Sharpe ratio (5Y)	1.43
Sortino ratio	1.92
Sortino ratio (3Y)	1.57
Sortino ratio (5Y)	2.38
Volume	7.1K
Weekly RSI	76.37
YTD price change	32.25%
YTD total return	32.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	368.8M
Shares change (QoQ)	0%
Shares change (YoY)	-1.52%
Shares held by insiders	0.12%
Shares held by institutions	92.4%
Short ratio	2.3 days

Deeper analysis on BCBA/TMO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/TMO report

Is a complete BCBA/TMO research report available?

No complete published report is available for bcba/TMO (BCBA/TMO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/TMO (BCBA/TMO)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/TMO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/TMO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/TMO

Frequently asked questions